MedPath

Effect of Spasticity on Tibial Nerve Entrapment

Active, not recruiting
Conditions
Neuropathy
Stroke
Interventions
Device: EMG
Registration Number
NCT06092190
Lead Sponsor
October 6 University
Brief Summary

Stroke is the most common cause of mortality and is one of the most common causes of morbidity in the world. Polyneuropathies and entrapment neuropathies are known as the complications of stroke

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1- A hundred patients with hemiplegia /paresis subsequent to a stroke as diagnosed by CT or MRI.

    2- A hundred patients from both sexes, their ages ranged from (55-65) years. 3- Body weight of patients was ranged from(55 -95 kg) ,while their height was from (151-185 cm) and BMI was ranged from (20-30 kg/m2).

    4- Duration of illness (6 - 9 months post stroke). 5- Patients have spasticity ranging from grade 1 to grade 3 according to modified Ashworth scale 6- Patients were medically stable

Exclusion Criteria
  • 1- Patients with lumbosacral sciatica that could mimic TTS or interfere with its evaluation 2- Patients with tibial neuropathy, significant polyneuropathy, or marked orthopedic abnormalities; 3- Patients with contractures 4- Patients with psychological disturbance or seizures 5- Systemic diseases known to cause TTS, such as diabetes mellitus, hypothyroidism, rheumatoid arthritis, or chronic renal failure;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group AEMG-
Group BEMG-
Primary Outcome Measures
NameTimeMethod
Electrodiagnostic testing30 minutes

Electrodiagnostic testing (electromyography and nerve conduction velocity) can objectively verify the tibial nerve dysfunction. Electrodiagnosis rests upon demonstrating impaired tibial nerve conduction across the tarsal tunnel in context of normal conduction. Compression results in damage to the myelin sheath and manifests as delayed latencies and slowed conduction velocities

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

October 6 University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath